Enzowid-D Tablet is a combination pharmaceutical formulation containing Trypsin (48 mg), Bromelain (90 mg), Rutoside (100 mg), and Diclofenac (50 mg), designed to provide effective anti-inflammatory, analgesic, and fibrinolytic effects. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of proteins, promoting the reduction of edema and inflammation by enhancing the absorption of inflammatory exudates. Rutoside, a bioflavonoid, acts as a vascular protector by strengthening capillary walls and reducing capillary permeability, thereby minimizing bruising and swelling. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase enzymes (COX-1 and COX-2), resulting in decreased synthesis of prostaglandins, which are mediators of pain and inflammation. The synergistic action of these components makes Enzowid-D effective in managing acute musculoskeletal conditions such as sprains, strains, contusions, and postoperative inflammation. It is also beneficial in chronic inflammatory disorders where pain and swelling are prominent symptoms. Enzowid-D should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, peptic ulcer disease, and bleeding disorders. Adherence to prescribed dosage and duration is essential to maximize therapeutic benefits while minimizing potential adverse effects.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.